Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
125 |
|
| Actual shortage: | 14 (11%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 106 (85%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
1 (7%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 400MG | TABLET | Actual shortage | 2022-11-14 | 2023-08-04 | 174659 |
| IBAVYR | 200MG | TABLET | Resolved | 2019-12-19 | 2020-03-11 | 101774 |
| IBAVYR | 200MG | TABLET | Resolved | 2020-03-16 | 2020-04-03 | 108738 |
| IBAVYR | 200MG | TABLET | Actual shortage | 2022-11-14 | 2023-08-04 | 174655 |
| MYINFLA | 0.5MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-10-11 | 2024-11-21 | 239848 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
Showing 1 to 3 of 3